Genome Compiler Overview

  • Founded

  • 2011

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 22

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $2.4M

Genome Compiler General Information

Description

Developer of a DNA design tool designed to help scientists design biological code. The company's DNA design tool helps scientist to edit whole genomes, order syntheses from different providers, collaborate in a secure cloud environment, direct access to algorithms and connection to synthesis and (genetic) construction services, enabling scientists to design, debug and compile the biological code into new living things.

Contact Information

Website
www.genomecompiler.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Parent Company
Twist Bioscience
Primary Office
  • Post Box 3635
  • Los Altos, CA 94024
  • United States
+1 (510) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome Compiler Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 07-Apr-2016 $2.4M 00.00 00.00 Completed Startup
7. Accelerator/Incubator 20-Sep-2015 00.00 Completed Startup
6. Early Stage VC 24-Oct-2013 00000 00.00 Completed Startup
5. Debt - General 23-Oct-2013 000 000 Completed Startup
4. Early Stage VC 01-Jan-2013 00.00 000 Completed Startup
3. Early Stage VC 01-Jan-2012 000 00.00 Completed Startup
2. Early Stage VC 21-Oct-2011 $500K $500K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Genome Compiler’s complete valuation and funding history, request access »

Genome Compiler Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a DNA design tool designed to help scientists design biological code. The company's DNA design tool helps s
Biotechnology
Los Altos, CA
22 As of 2016
00.00
0.00 0000-00-00
000000&0 00.00

000000

gna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
000000000 00000 (0000000000)
Baltimore, MD
000 As of 0000
00000
0000 0000-00-00
000000&0 00000

000000

s aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
0000000000000
Ebersberg, Germany
00 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genome Compiler Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD 000 00000 000000&0 00000
00000000 00000000 Accelerator/Incubator Backed Ebersberg, Germany 00 000000000000
0000000 0000000000 Corporate Backed or Acquired Santa Fe, NM 000 000000&0
00000000 Corporation Budapest, Hungary 000
000000000 Venture Capital-Backed Ann Arbor, MI 00 000.00 00000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Genome Compiler Patents

  • 6

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Genome Compiler Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2751729-A1 System for polynucleotide construct design, visualization and transactions to manufacture the same Active 01-Sep-2011 000000000
US-20220246236-A1 Systems for polynucleotide construct design, visualization and transactions to manufacture the same Pending 01-Sep-2011 000000000
ES-2844529-T3 System for the design, visualization and transactions of polynucleotide constructions to manufacture them Active 01-Sep-2011 000000000
EP-2751729-B1 System for polynucleotide construct design, visualization and transactions to manufacture the same Active 01-Sep-2011 000000000
EP-2751729-A4 System for polynucleotide construct design, visualization and transactions to manufacture the same Active 01-Sep-2011 G16B25/00
To view Genome Compiler’s complete patent history, request access »

Genome Compiler Executive Team (7)

Name Title Board Seat Contact Info
Roy Nevo Co-Founder & Chief Technology Officer
Daniel Chadash Vice President, Product
You’re viewing 2 of 7 executive team members. Get the full list »

Genome Compiler Board Members (3)

Name Representing Role Since
Amos Barzilay Ph.D Self Chairman of the Board 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Genome Compiler Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genome Compiler Former Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Autodesk Corporation Minority 000 0000 000000 0
Dan Shapiro Angel (individual) Minority 000 0000 000000 0
David Beyer Angel (individual) Minority 000 0000 000000 0
David Williams Angel (individual) Minority 000 0000 000000 0
Donald Hutchison Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 25 investors. Get the full list »

Ready to get started?

Request a free trial